Zaltrap (ziv-aflibercept) Injection

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)   June 2016 ADVERSE REACTIONS Post Marketing Experience (added) Cardiac disorders: Cardiac failure, Ejection fraction...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts